Inventiva (IVA) Current Taxes (2019 - 2025)

Inventiva's (IVA) quarterly Current Taxes came in at $5.7 million in Q2 2025, up 39.93% quarter-over-quarter from $4.1 million in Q4 2024.

Inventiva (IVA) Current Taxes (2019 - 2025) Analysis & Trends

Inventiva's Current Taxes history runs 4 years deep, the most recent figure standing at $5.7 million for Q2 2025.

On a quarterly basis, Current Taxes changed N/A year-over-year to $5.7 million in Q2 2025; TTM through Jun 2025 was $5.7 million, a N/A change from a year earlier, with the FY2024 full-year figure at $4.1 million, changed N/A from the prior year.
Current Taxes grew to $5.7 million in Q2 2025 per IVA's latest filing, from $4.1 million in the prior quarter.
Across five years, Current Taxes topped out at $5.7 million in Q2 2025 and bottomed at $4.1 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	63.52 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	49.00 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Inventiva	842.48 Mn	842.48 Mn	-	-

Download Data